These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10565791)

  • 1. Dosimetry study in patients with autonomous thyroid nodule who are candidates for radioiodine therapy.
    Reschini E; Matheoud R; Canzi C; Castellani M; Galelli M; Ferrari C; Paracchi A; Gerundini P
    J Nucl Med; 1999 Nov; 40(11):1928-34. PubMed ID: 10565791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific dosimetry for radioiodine therapy of the autonomous thyroid nodule.
    Matheoud R; Canzi C; Reschini E; Zito F; Voltini F; Gerundini P
    Med Phys; 2003 May; 30(5):791-8. PubMed ID: 12772986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATE based Monte Carlo simulation of planar scintigraphy to estimate the nodular dose in radioiodine therapy for autonomous thyroid adenoma.
    Hammes J; Pietrzyk U; Schmidt M; Schicha H; Eschner W
    Z Med Phys; 2011 Dec; 21(4):290-300. PubMed ID: 21983024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity.
    Clerc J; Dagousset F; Izembart M; Jais JP; Heshmati HM; Alcaïs A; Chevalier A; Léger AF; Barritault L
    J Nucl Med; 1995 Feb; 36(2):217-23. PubMed ID: 7830117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of thyroid scintigraphies after 131I therapy of solitary autonomous thyroid nodules.
    Nygaard B; Jarløv AE; Hegedüs L; Schaadt B; Kristensen LO; Hansen JM
    Thyroid; 1994; 4(2):167-71. PubMed ID: 7522683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the thyroid technetium-99m scintigram after antithyroid and subsequent radioiodine treatment for solitary autonomous nodules.
    Nygaard B
    Thyroid; 1998 Mar; 8(3):223-7. PubMed ID: 9545108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule.
    Amato E; Lizio D; Ruggeri RM; Raniolo M; Campennì A; Baldari S
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):560-6. PubMed ID: 21242948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount.
    Schiavo M; Bagnara MC; Pomposelli E; Altrinetti V; Calamia I; Camerieri L; Giusti M; Pesce G; Reitano C; Bagnasco M; Caputo M
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):301-7. PubMed ID: 23486350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioiodine therapy for combined disseminated and nodular thyroid autonomy. Results after using a correction term for the disseminated part].
    Vogt H; Wengenmair H; Kopp J; Dorn R; Otto I; Sciuk J
    Nuklearmedizin; 2006; 45(3):101-4. PubMed ID: 16710504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity.
    Als C; Rösler H; Kinser JA
    J Nucl Med; 1996 Feb; 37(2):401-3. PubMed ID: 8667087
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
    Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH
    Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiometabolic therapy of the autonomous thyroid nodule].
    Mariotti S; Caturegli P; Barbesino G; Ceccarelli C; Lippi F; Marinò M; Manetti L; Martino E; Pinchera A
    Minerva Endocrinol; 1993 Dec; 18(4):155-63. PubMed ID: 8190055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in radioiodine turnover in patients with autonomous thyroid adenoma treated with percutaneous ethanol injection.
    Paracchi A; Reschini E; Ferrari C; Ciocia G; Castellani M
    J Nucl Med; 1998 Jun; 39(6):1012-6. PubMed ID: 9627335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine isotope ¹³¹I therapy for toxic nodular goitre: treatment efficacy parameters.
    Szumowski P; Rogowski F; Abdelrazek S; Kociura-Sawicka A; Sokolik-Ostasz A
    Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):7-13. PubMed ID: 23047567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
    Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
    Urbannek V; Schmidt M; Moka D; Hillger HW; Voth E; Wellner U; Schicha H
    Nuklearmedizin; 2000; 39(4):108-12. PubMed ID: 10919161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules.
    Døssing H; Bennedbaek FN; Bonnema SJ; Grupe P; Hegedüs L
    Eur J Endocrinol; 2007 Jul; 157(1):95-100. PubMed ID: 17609407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study.
    Zingrillo M; Torlontano M; Ghiggi MR; Frusciante V; Varraso A; Liuzzi A; Trischitta V
    Thyroid; 2000 Nov; 10(11):985-9. PubMed ID: 11128727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomous functioning thyroid nodules and 131I in diagnosis and therapy after 50 years of experience: what is still open to debate?
    Ronga G; Filesi M; D'Apollo R; Toteda M; Di Nicola AD; Colandrea M; Travascio L; Vestri AR; Montesano T
    Clin Nucl Med; 2013 May; 38(5):349-53. PubMed ID: 23531770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.